FABTECH147.10

Fabtech Technologies Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹654 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations68.0189.562.8158.575.0
Other Income0.93.77.19.73.2
Total Income69.0193.269.9168.278.2
Expenses
+ Purchases of Stock-in-Trade35.976.440.899.132.3
+ Changes in Inventories7.122.00.14.19.4
+ Employee Benefit Expense10.519.511.112.710.2
+ Finance Costs1.32.40.90.90.9
+ Depreciation & Amortisation1.42.71.31.31.3
+ Other Expenses20.647.322.220.418.9
Total Expenses77.0170.476.4138.572.9
EBITDA-6.224.2-11.522.24.2
EBIT-7.621.5-12.820.93.0
Profit
PBT before Exceptional Items-8.022.9-6.529.85.3
+ Exceptional Items1.81.80.00.00.0
Pretax Income-6.224.6-6.529.85.3
+ Current Tax0.64.6-0.16.61.2
+ Deferred Tax-0.7-1.5-0.91.3-0.1
Tax Expense-0.13.1-1.07.81.0
+ Share of Associates & JVs0.00.4-0.10.1-0.0
Net Income-6.122.0-5.722.14.2
+ Net Income — Continuing Ops-6.221.6-5.521.94.2
+ Other Comprehensive Income-0.0-0.10.10.1-0.0
Total Comprehensive Income-6.221.9-5.622.24.2
Net Income to Common-6.122.0-5.74.2
Minority Interest0.00.00.0-0.0
Per Share
Basic EPS-1.896.79-1.565.750.95
Diluted EPS-1.896.79-1.565.750.95
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.0-0.10.10.1-0.0
+ Items NOT to be Reclassified to P&L-0.0-0.10.10.2-0.0
+ Tax on Items NOT to be Reclassified-0.0-0.00.00.0-0.0
Comprehensive Income — Owners of Parent-6.2-0.1-5.64.2
Comprehensive Income — Non-controlling Interests0.021.90.0-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations-1.896.79-1.565.750.95
Diluted EPS — Continuing Operations-1.896.79-1.565.750.95
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit24.991.121.855.333.4
Gross Margin %36.6848.0534.7834.9044.50
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)-8.022.9-6.529.85.3
− Exceptional Items (reconciliation)1.81.80.00.00.0
Net Income Adj (tax-effected)-7.920.4-5.722.14.2
EPS Adj-2.436.31-1.565.750.95
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.00
Paid Up Equity Capital32.432.444.544.544.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.